HomeCompareHOLX vs ACN

HOLX vs ACN: Dividend Comparison 2026

HOLX yields 2.65% · ACN yields 3.30%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACN wins by $45.31M in total portfolio value
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
ACN
ACN
● Live price
3.30%
Share price
$197.55
Annual div
$6.52
5Y div CAGR
85.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.34M
Annual income
$40,254,140.02
Full ACN calculator →

Portfolio growth — HOLX vs ACN

📍 ACN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXACN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + ACN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
ACN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
ACN
Annual income on $10K today (after 15% tax)
$280.54/yr
After 10yr DRIP, annual income (after tax)
$34,216,019.02/yr
At 15% tax rate, ACN beats the other by $34,215,752.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + ACN for your $10,000?

HOLX: 50%ACN: 50%
100% ACN50/50100% HOLX
Portfolio after 10yr
$22.68M
Annual income
$20,127,227.02/yr
Blended yield
88.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ACN right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
ACN
Analyst Ratings
39
Buy
13
Hold
1
Sell
Consensus: Buy
Price Target
$299.92
+51.8% upside vs current
Range: $265.00 — $330.00
Altman Z
4.3
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
ACN buys
0
No recent congressional trades found for HOLX or ACN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXACN
Forward yield2.65%3.30%
Annual dividend / share$2.00$6.52
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%85.1%
Portfolio after 10y$23.6K$45.34M
Annual income after 10y$314.03$40,254,140.02
Total dividends collected$2.9K$44.91M
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusHoldBuy
Analyst price target$77.80$299.92

Year-by-year: HOLX vs ACN ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrACN PortfolioACN Income/yrGap
1← crossover$10,965$264.73$11,311$610.91$346.00ACN
2$12,004$271.27$13,298$1,195.36$1.3KACN
3$13,121$277.55$16,660$2,431.14$3.5KACN
4$14,323$283.54$23,095$5,268.91$8.8KACN
5$15,615$289.27$37,347$12,635.37$21.7KACN
6$17,003$294.73$75,308$35,346.62$58.3KACN
7$18,493$299.93$203,877$123,297.57$185.4KACN
8$20,093$304.87$795,585$577,436.45$775.5KACN
9$21,809$309.57$4,749,302$3,898,026.13$4.73MACN
10$23,649$314.03$45,335,893$40,254,140.02$45.31MACN

HOLX vs ACN: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

ACNTechnology

Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management, intelligent automation comprises robotic process automation, natural language processing, and virtual agents, and liquid application management services, as well as program, project, and service management services; strategy consulting services; critical data elements, data management and governance, data platform and architecture, product-based organization and skills, business adoption, and value realization services; engineering, and research and development digitization; smart connected product design and development; product platform engineering and modernization; product as-a-service enablement; products related to production and operations; autonomous robotics systems; the digital transformation of capital projects; and digital industrial workforce solutions. It also provides data-enabled operating models; technology consulting and artificial intelligence services; services related to talent and organization/human potential; digital commerce; infrastructure services, such as hybrid cloud, network, digital workplace and collaboration, service and experience management, infrastructure as code, and managed edge and IoT devices; cyber defense, applied cybersecurity, managed security, OT security, security strategy and risk, and industry security products; services related to technology innovation; and intelligent automation services. In addition, the company offers cloud, ecosystem, marketing, supply chain management, zero-based budgeting, customer experience, finance consulting, mergers and acquisitions, and sustainability services. Accenture plc was founded in 1951 and is based in Dublin, Ireland.

Full ACN Calculator →
📬

Get this HOLX vs ACN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.